ResearcherGanzhou People's HospitalActive in the last 2 years

Xiao Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2263-4309; OpenAlex author ID A5047831707. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 2 papers

Papers 2

TYROBP overexpression alters macrophage phenotype and enhances pancreatic cancer stemness through STAT3 and PKM2 signaling. Co-author DOI 10.1016/j.cellsig.2025.111949 ↗
TYROBP facilitates metastatic progression in pancreatic cancer through CTSZ-driven glycolytic rewiring and macrophage recruitment. Last author DOI 10.1016/j.cellsig.2025.112142 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dingwen Zhong · 2 shared papers, 2025 · strength 0.59
- Paper TYROBP facilitates metastatic progression in pancreatic cancer through CTSZ-driven glycolytic rewiring and macrophage r… DOI 10.1016/j.cellsig.2025.112142 ↗
- Paper TYROBP overexpression alters macrophage phenotype and enhances pancreatic cancer stemness through STAT3 and PKM2 signal… DOI 10.1016/j.cellsig.2025.111949 ↗
Zheng Wang · 1 shared paper, 2025 · strength 0.28
- Paper TYROBP overexpression alters macrophage phenotype and enhances pancreatic cancer stemness through STAT3 and PKM2 signal… DOI 10.1016/j.cellsig.2025.111949 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.